$4.46
-0.23-4.8%
Last update: Nov 5, 3:43 PM
Clover Health Investments Corp
CLOVNASDAQ
The average analyst price target for Clover Health Investments is $5, 12.0% above the current price. Of 5 analysts, 3 rate it Buy and 2 Hold. Targets range from $2.50 to $6. The latest change came on Oct 28, 2026, when Needham initiated coverage of Clover Health Investments with a Buy rating and a $6 price target.
Price Target Range — 8 Quarters
Analyst Consensus — 5 Analysts
Rating Trend — Last 9 Months
